Loading...
COLTENE Holding AG
CLHLF•PNK
Healthcare
Medical - Instruments & Supplies
$76.25
$15.09(24.67%)
COLTENE Holding AG (CLHLF) Financial Performance & Income Statement Overview
Review COLTENE Holding AG (CLHLF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.06%
↑ 3.06%
Operating Income Growth
36.89%
↑ 36.89%
Net Income Growth
71.31%
↑ 71.31%
Operating Cash Flow Growth
9.96%
↑ 9.96%
Operating Margin
7.60%
↑ 7.60%
Gross Margin
45.64%
↑ 45.64%
Net Profit Margin
5.17%
↑ 5.17%
ROE
11.82%
↑ 11.82%
ROIC
15.92%
↑ 15.92%
COLTENE Holding AG (CLHLF) Income Statement & Financial Overview
Analyze COLTENE Holding AG’s CLHLF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $122.66M | $127.50M | $111.30M | $131.43M |
| Cost of Revenue | $89.41M | $42.52M | $87.30M | $95.77M |
| Gross Profit | $33.25M | $84.98M | $24.001M | $35.67M |
| Gross Profit Ratio | $0.27 | $0.67 | $0.22 | $0.27 |
| R&D Expenses | $0.00 | $0.00 | $10.24M | $0.00 |
| SG&A Expenses | $19.38M | $47.08M | $18.81M | $21.25M |
| Operating Expenses | $19.38M | $72.002M | $18.82M | $21.24M |
| Total Costs & Expenses | -$108.79M | $114.53M | $106.12M | $117.005M |
| Interest Income | $0.00 | $543000.00 | $0.00 | $1.16M |
| Interest Expense | $903000.00 | $0.00 | $2.33M | $1.16M |
| Depreciation & Amortization | $3.44M | $3.46M | $3.40M | $3.45M |
| EBITDA | $17.30M | $16.98M | $8.58M | $17.87M |
| EBITDA Ratio | $0.14 | $0.13 | $0.08 | $0.14 |
| Operating Income | $13.86M | $12.98M | $5.18M | $14.43M |
| Operating Income Ratio | $0.11 | $0.10 | $0.05 | $0.11 |
| Other Income/Expenses (Net) | -$903000.00 | $543000.00 | -$2.33M | -$1.16M |
| Income Before Tax | $12.96M | $13.52M | $2.86M | $13.26M |
| Income Before Tax Ratio | $0.11 | $0.11 | $0.03 | $0.10 |
| Income Tax Expense | $2.91M | $3.10M | $931000.00 | $3.24M |
| Net Income | $10.05M | $10.42M | $1.93M | $10.02M |
| Net Income Ratio | $0.08 | $0.08 | $0.02 | $0.08 |
| EPS | $1.68 | $1.74 | $0.32 | $1.68 |
| Diluted EPS | $1.68 | $1.74 | $0.32 | $1.68 |
| Weighted Avg Shares Outstanding | $5.98M | $5.99M | $5.98M | $5.98M |
| Weighted Avg Shares Outstanding (Diluted) | $5.98M | $5.99M | $5.98M | $5.98M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan